How High Is the 5-Year Colorectal Cancer Survival Rate Heading Into 2026?

For people diagnosed with colorectal cancer in Korea between 2019 and 2023, the 5-year relative survival rate stands at 75.6% — a nationwide figure, not the record of any single hospital.

Key takeaways

• Korea's 5-year relative survival rate for colorectal cancer is 75.6% (National Cancer Registration Statistics 2019–2023, Central Cancer Registry, National Cancer Center Korea).
• Over the same period, the 5-year relative survival rate for all cancers combined in Korea was 73.7%, meaning colorectal cancer runs somewhat higher than the national all-cancer average.
• In the United States, SEER statistics (2016–2022) put the 5-year relative survival rate for colorectal cancer at 65.4%. Both figures are national population statistics, not results from any specific hospital.
• Much of the gap comes down to early detection: Korea runs a national screening program starting at age 50 that uses a fecal occult blood test, followed by colonoscopy if the result is positive.
• Keep in mind that a survival rate is a population average — it does not predict what will happen to any one individual.

Why does the 5-year colorectal cancer survival rate differ by country?

• Differences in survival rates owe more to timing of detection than to differences in treatment technology. Korea performs an annual fecal occult blood test as part of national screening from age 50, with colonoscopy follow-up for positive results — so a comparatively larger share of cases are caught at the polyp stage or as early-stage cancer.
• Colorectal cancer has a well-understood pathway in which a polyp slowly develops into cancer over time, so simply removing polyps during colonoscopy can itself function as prevention.
• It's worth stressing that the two figures — Korea's 75.6% versus the US SEER rate of 65.4% — reflect nationwide cancer-patient population statistics in each country, not the treatment outcomes of any particular hospital.

How do treatment and prognosis differ by stage?

• Staging follows the TNM system. Stage 0–1 means the cancer is confined to the mucosa or a shallow layer with no lymph node spread; stage 2 means it has grown deep into the bowel wall but without lymph node involvement; stage 3 means lymph nodes are involved; and stage 4 means the cancer has spread to distant organs such as the liver or lungs.
• Step 1: colonoscopy and biopsy to confirm location and size → Step 2: abdominal and chest CT (plus pelvic MRI for rectal cancer) to assess metastasis and lymph nodes → Step 3: CEA tumor marker testing, and for advanced or metastatic disease, biomarker testing for MSI/MMR, RAS, BRAF, and HER2 → Step 4: stage-appropriate treatment (endoscopic resection, surgery, chemotherapy, or radiation therapy) → Step 5: follow-up monitoring at set intervals.
• Even in stage 4, colorectal cancer can sometimes be treated with curative intent if metastatic sites in the liver or lungs can be surgically removed — giving it a comparatively wider range of treatment options at stage 4 than many other cancers.

FAQ — If caught early, can colorectal cancer be treated without surgery?

Early colorectal cancer confined to the mucosa, or cancer that has developed within a polyp, can often be fully treated with endoscopic resection (EMR or ESD) performed during colonoscopy. This typically requires only a one- or two-day hospital stay and does not involve cutting out any part of the bowel. If the removed tissue shows depth of invasion or resection margins outside the acceptable range, the case may move on to additional surgery.

FAQ — If I have rectal cancer, will I definitely need a colostomy?

This depends on the tumor's location, its distance from the anus, and how well it responds to preoperative chemoradiation. Standard practice for rectal cancer that has grown deep into the bowel wall or spread to lymph nodes involves shrinking the tumor with radiation and chemotherapy before surgical removal, and in cases where the tumor shrinks enough, anus-preserving surgery can become possible. It's also common to create a temporary stoma that is later reversed a few months afterward.

Sources and notes

• This article is based on the National Cancer Registration Statistics 2019–2023 (Central Cancer Registry, National Cancer Center Korea) and SEER 2016–2022 statistics.
• This content is provided for general medical information purposes only. Diagnosis, treatment approach, and outcomes may vary depending on individual circumstances. Please consult with your medical team to determine the diagnosis and treatment appropriate for you.